MetLife Director Acquires 562 Shares Through Board Compensation Program

MetLife director Denise M. Morrison reported the acquisition of 562 shares of common stock on June 17, 2025 as part of the company's non-management director compensation arrangements.

Rhea-AI Filing Summary

MetLife director Denise M. Morrison reported the acquisition of 562 shares of common stock on June 17, 2025 as part of the company's non-management director compensation arrangements. The shares were acquired at $0 cost as part of director retainer fees paid in company stock.

Following this transaction, Morrison now beneficially owns a total of 32,817 shares directly. The filing indicates this is a routine compensation-related acquisition for board service rather than an open market purchase.

• Transaction Type: Stock Award (Compensation)
• Form of Ownership: Direct
• Role: Non-Management Director
• No derivative securities were involved in this transaction

Insider Trade Summary

Grant/Award: 562 shares

Grant/Award 1 txn

Insider MORRISON DENISE M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	562	$0.00	$0.00

Holdings After Transaction: Common Stock — 32,817 shares (Direct)

Footnotes (1)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MetLife (MET) shares did Director Denise Morrison acquire on June 17, 2025?

According to the Form 4 filing, Director Denise Morrison acquired 562 shares of MetLife (MET) common stock on June 17, 2025 as part of the non-management director compensation arrangements.

What is the total number of MET shares Denise Morrison owns after the June 17, 2025 transaction?

Following the reported transaction, Denise Morrison beneficially owns 32,817 shares of MetLife (MET) common stock directly.

What was the purchase price for MET shares acquired by Director Morrison?

The shares were acquired at $0 per share, as they were granted as part of MetLife's non-management director retainer fees paid in company common stock rather than purchased on the open market.

What type of ownership does Denise Morrison have in her MET shares?

According to the Form 4, Denise Morrison has Direct (D) ownership of her MetLife shares, with no indirect beneficial ownership reported.

What is Denise Morrison's role at MetLife (MET)?

The Form 4 indicates that Denise Morrison serves as a Director (non-management) on MetLife's board, as shown by the 'X' marked in the Director box under Section 5 of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 04:33 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MORRISON DENISE M

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		A(1)		562	A	$0	32,817	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Remarks:

	/s/ Morgan Mayes, Authorized Signer	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.